eHEALTH Bureau Stempeutics Research, a group company of Manipal Education & Medical Group and a leading stem cell research company has announced the appointment of Dr Anish Sen Majumdar as the Chief Scientific Officer. Dr Majumdar brings with him an in-depth knowledge and rich experience in the field of stem cell research from both India and abroad. Prior to joining Stempeutics, he worked with the Reliance Life Sciences center as vice president. His responsibility included developing and directing research and developmental activities in the areas of both embryonic and adult stem cells including mesenchymal stem cells, ocular stem cells and other somatic cells for therapeutic use in various types of degenerative diseases. Dr Majumdar started his career with Geron Corporation, an internationally known stem cell company headquartered at California. At Geron, he joined as a Sr Staff Scientist and went on to become a Sr Director of Cell Therapy Research/Immunology in 2005. He was responsible for developing dendrite cell based anti-tumor (telomerase antigen) vaccine, human ES cell derived pancreatic islets for diabetes therapy, human ES cell derived ologodendrocyte progenitor cells for spinal cord injury etc.Speaking on his appointment, Dr BN Manohar, CEO, Stempeutics said: “We are delighted to welcome Dr Anish Sen Majumdar to Stempeutics as he has a proven track-record of break-through thinking in the stem cell research field. We are really looking forward to some spectacular research breakthroughs under his guidance”.Dr Majumdar obtained his PhD in Biochemistry from the University of Calcutta. He completed his postdoctoral research from Pennsylvania School of Medicine. He has also to his credit various research articles in internationally acclaimed journals such as Infection and Immunity, Biochemistry, JBC, JCB, Nature, Journal of Immunology, Cell, Journal of Experimental Medicine, Stem Cells, Stem Cell Research etc to name a few. He has also been a member of scientific organisations including American Association for the Advancement of Science (AAAS) and International Society for Stem Cell Research (ISSCR).